Joana Goncalves, Chief Medical Officer at Oruka Therapeutics, Inc. (ORKA), sold 7,000 shares at $73.89 ($524K) on 2026-10-15, disclosed to the SEC on 2026-10-15.
Scheduled sale ($524k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.89 | 2,853 | $211K | 40.3% |
| 2 | $74.69 | 1,847 | $138K | 26.3% |
| 3 | $75.48 | 1,400 | $106K | 20.2% |
| 4 | $76.67 | 700 | $54K | 10.2% |
| 5 | $77.71 | 200 | $16K | 3.0% |
| Total | $74.81 avg | 7,000 |
| $524K |
| 100% |
| Filing → |
| ORKA | SELL | 2026-07-15 | $604K | — | Filing → |
| ORKA | SELL | 2026-06-15 | $551K | — | Filing → |
| ORKA | SELL | 2026-05-15 | $433K | — | Filing → |